Topical treatments incorporating
A topical formulation comprising a Cannabis derived botanical drug product, wherein the concentration of each, cannabidiol and tetrahydrocannabinol, in the topical formulation is greater than 2 milligrams per kilogram.
1. A topical emulsion, consisting essentially of:
an extract of Cannabis sativia or an extract of Cannabis indica ; and
a compound selected from the group consisting of calamine, dodecyl sulfate, sodium lauryl sulfate, monooleate, monolaurate, monopalmitate, monostearate esters, lecithin, and sodium docusate which are present in an amount of at least 0.01 wt. % in the topical emulsion,
wherein the concentration of a cannabinoid selected from the group consisting of tetrahydrocannabinol and cannabidiol in the topical emulsion is greater than 2 milligrams per kilogram.
2. The emulsion of claim 1 , wherein the compound is calamine.
3. The emulsion of claim 1 , wherein the compound is dodecyl sulfate.
4. The emulsion of claim 1 , wherein the compound is the sodium lauryl sulfate.
5. The emulsion of claim 1 , wherein the compound is the monooleate.
6. The emulsion of claim 1 , wherein the compound is the monolaurate.
7. The emulsion of claim 1 , wherein the compound is the monopalmitate.
8. The emulsion of claim 1 , wherein compound is the monostearate esters.
9. The emulsion of claim 1 , wherein compound is the lecithin.
10. The emulsion of claim 1 , wherein compound is the sodium docusate.